Skip to main content
. 2014 Aug 7;20(29):9699–9715. doi: 10.3748/wjg.v20.i29.9699

Figure 12.

Figure 12

Adsorption dependent release of interleukin-1 receptor antagonist, and hepatocyte growth factor from myeloid lineage leucocytes (granulocytes and monocytes) in in-vitro setting. Hepatocyte growth factor (HGF) is known to promote ulcer healing and cell regeneration, while interleukin-1 receptor antagonist (IL-1ra) is strongly anti-inflammatory[113]. GMA: Granulocyte and monocyte apheresis.